| Winters-Stone, Kerri M |
Oregon Health & Science University
United States |
Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer |
5R01CA248059-04 |
Goli Samimi, Ph.D., M.P.H. |
| Hill, Joshua Aiden |
Fred Hutchinson Cancer Center
United States |
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy |
1R01CA276040-01A1 |
Sharon Ross, Ph.D., M.P.H. |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
| Gudas, Lorraine J |
Weill Medical Coll Of Cornell Univ
United States |
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention |
1R01CA270248-01A1 |
Winfred Malone, Ph.D., M.P.H. |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
| Huh, Warner King |
University Of Alabama At Birmingham
United States |
Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) |
1R01CA279021-01A1 |
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
| Xu, Xiangxi Mike |
University Of Miami School Of Medicine
United States |
Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy |
1R01CA286527-01 |
Rachel Altshuler, Ph.D. |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
| Bower, Julienne E |
University Of California Los Angeles
United States |
Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings |
1R01CA282416-01A1 |
Brennan Streck, Ph.D., R.N., M.P.H. |